Taxpayers

The AARP Public Policy Institute's latest report in their Rx Price Watch series highlights the impact of prescription drug price increases on consumers, employers, private insurers, and taxpayers, affecting programs like Medicare and Medicaid. The report presents annual and 15-year cumulative price changes, until the end of 2020, for a comprehensive set of 943 prescription drugs widely used by older adults, emphasizing the potential long-term consequences on health care coverage costs, taxes, and public programs.